Skip to main content
Erschienen in: Heart and Vessels 4/2020

22.10.2019 | Original Article

Ischemic stroke risk during post-discharge phases of heart failure: association of left ventricular concentric geometry

verfasst von: Yasuhiro Shintani, Hiroyuki Takahama, Yasuhiro Hamatani, Kunihiro Nishimura, Hideaki Kanzaki, Kengo Kusano, Teruo Noguchi, Kazunori Toyoda, Satoshi Yasuda, Chisato Izumi

Erschienen in: Heart and Vessels | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

Despite a higher risk of ischemic stroke in hospitalized patients with acute heart failure (HF), little is known about the risk of ischemic stroke during the post-discharge phases of HF. Here we investigated (1) the ischemic stroke incidence rate during the post-discharge phases among HF patients receiving standard treatments; (2) the association between ischemic stroke incidence and clinical background, including cardiac structure and function. Among 950 patients who required hospitalization for HF (median duration: 19 days) at our institution, where they received standard treatments, we investigated stroke occurrences during the 2-year period following their discharge and retrospectively evaluated their clinical data. Relative wall thickness (RWT) and left ventricular (LV) mass were determined based on echocardiographic measurements and then used to determine LV geometric patterns. During the follow-up period, ischemic stroke occurred in 25 patients (2.6%) after hospital discharge (1.4 per 100 patient-years). The incidence rate of IS tended to be higher in patients with AF than those without AF (1.8 vs. 1.0 per 100 patient-years, respectively). Notably, multivariate analysis revealed a significant association between RWT and ischemic stroke risk (p < 0.05). RWT was associated with ischemic stroke risk in patients with AF or left atrial enlargement, but not in patients without them. These findings suggest that even with standard HF treatments, the risk of ischemic stroke is high in patients with HF. Moreover, LV concentric geometry is a significant risk factor for ischemic stroke in patients with HF, especially in those with left atrial remodeling and/or AF.
Literatur
1.
Zurück zum Zitat Adelborg K, Szepligeti S, Sundboll J, Horvath-Puho E, Henderson VW, Ording A, Pedersen L, Sorensen HT (2017) Risk of stroke in patients with heart failure: A population-based 30-year cohort study. Stroke 48:1161–1168CrossRef Adelborg K, Szepligeti S, Sundboll J, Horvath-Puho E, Henderson VW, Ording A, Pedersen L, Sorensen HT (2017) Risk of stroke in patients with heart failure: A population-based 30-year cohort study. Stroke 48:1161–1168CrossRef
2.
Zurück zum Zitat Alberts VP, Bos MJ, Koudstaal P, Hofman A, Witteman JC, Stricker B, Breteler M (2010) Heart failure and the risk of stroke: the Rotterdam Study. Eur J Epidemiol 25:807–812CrossRef Alberts VP, Bos MJ, Koudstaal P, Hofman A, Witteman JC, Stricker B, Breteler M (2010) Heart failure and the risk of stroke: the Rotterdam Study. Eur J Epidemiol 25:807–812CrossRef
3.
Zurück zum Zitat Witt BJ, Brown RD Jr, Jacobsen SJ, Weston SA, Ballman KV, Meverden RA, Roger VL (2006) Ischemic stroke after heart failure: a community-based study. Am Heart J 152:102–109CrossRef Witt BJ, Brown RD Jr, Jacobsen SJ, Weston SA, Ballman KV, Meverden RA, Roger VL (2006) Ischemic stroke after heart failure: a community-based study. Am Heart J 152:102–109CrossRef
4.
Zurück zum Zitat Hamatani Y, Nagai T, Nakai M, Nishimura K, Honda Y, Nakano H, Honda S, Iwakami N, Sugano Y, Asaumi Y, Aiba T, Noguchi T, Kusano K, Toyoda K, Yasuda S, Yokoyama H, Ogawa H, Anzai T (2018) Elevated plasma d-dimer level is associated with short-term risk of ischemic stroke in patients with acute heart failure. Stroke 49:1737–1740CrossRef Hamatani Y, Nagai T, Nakai M, Nishimura K, Honda Y, Nakano H, Honda S, Iwakami N, Sugano Y, Asaumi Y, Aiba T, Noguchi T, Kusano K, Toyoda K, Yasuda S, Yokoyama H, Ogawa H, Anzai T (2018) Elevated plasma d-dimer level is associated with short-term risk of ischemic stroke in patients with acute heart failure. Stroke 49:1737–1740CrossRef
5.
Zurück zum Zitat Iguchi M, Tezuka Y, Ogawa H, Hamatani Y, Takagi D, An Y, Unoki T, Ishii M, Masunaga N, Esato M, Tsuji H, Wada H, Hasegawa K, Abe M, Lip GYH, Akao M (2018) Incidence and risk factors of stroke or systemic embolism in patients with atrial fibrillation and heart failure—the Fushimi AF Registry. Circ J 82:1327–1335CrossRef Iguchi M, Tezuka Y, Ogawa H, Hamatani Y, Takagi D, An Y, Unoki T, Ishii M, Masunaga N, Esato M, Tsuji H, Wada H, Hasegawa K, Abe M, Lip GYH, Akao M (2018) Incidence and risk factors of stroke or systemic embolism in patients with atrial fibrillation and heart failure—the Fushimi AF Registry. Circ J 82:1327–1335CrossRef
6.
Zurück zum Zitat Hamatani Y, Iguchi M, Nakamura M, Ohtani R, Yamashita Y, Takagi D, Unoki T, Ishii M, Masunaga N, Ogawa H, Hamatani M, Abe M, Akao M (2016) Incidence and predictors of ischemic stroke during hospitalization for congestive heart failure. Heart Vessels 31:1154–1161CrossRef Hamatani Y, Iguchi M, Nakamura M, Ohtani R, Yamashita Y, Takagi D, Unoki T, Ishii M, Masunaga N, Ogawa H, Hamatani M, Abe M, Akao M (2016) Incidence and predictors of ischemic stroke during hospitalization for congestive heart failure. Heart Vessels 31:1154–1161CrossRef
7.
Zurück zum Zitat Popovic B, Zannad F, Louis H, Clerc-Urmes I, Lakomy C, Gibot S, Denis CV, Lacolley P, Regnault V (2019) Endothelial-driven increase in plasma thrombin generation characterising a new hypercoagulable phenotype in acute heart failure. Int J Cardiol 274:195–201CrossRef Popovic B, Zannad F, Louis H, Clerc-Urmes I, Lakomy C, Gibot S, Denis CV, Lacolley P, Regnault V (2019) Endothelial-driven increase in plasma thrombin generation characterising a new hypercoagulable phenotype in acute heart failure. Int J Cardiol 274:195–201CrossRef
8.
Zurück zum Zitat Zannad F, Stough WG, Regnault V, Gheorghiade M, Deliargyris E, Gibson CM, Agewall S, Berkowitz SD, Burton P, Calvo G, Goldstein S, Verheugt FW, Koglin J, O'Connor CM (2013) Is thrombosis a contributor to heart failure pathophysiology? Possible mechanisms, therapeutic opportunities, and clinical investigation challenges. Int J Cardiol 167:1772–1782CrossRef Zannad F, Stough WG, Regnault V, Gheorghiade M, Deliargyris E, Gibson CM, Agewall S, Berkowitz SD, Burton P, Calvo G, Goldstein S, Verheugt FW, Koglin J, O'Connor CM (2013) Is thrombosis a contributor to heart failure pathophysiology? Possible mechanisms, therapeutic opportunities, and clinical investigation challenges. Int J Cardiol 167:1772–1782CrossRef
9.
Zurück zum Zitat Vaziri SM, Larson MG, Benjamin EJ, Levy D (1994) Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham heart study. Circulation 89:724–730CrossRef Vaziri SM, Larson MG, Benjamin EJ, Levy D (1994) Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham heart study. Circulation 89:724–730CrossRef
10.
Zurück zum Zitat Di Tullio MR, Zwas DR, Sacco RL, Sciacca RR, Homma S (2003) Left ventricular mass and geometry and the risk of ischemic stroke. Stroke 34:2380–2384CrossRef Di Tullio MR, Zwas DR, Sacco RL, Sciacca RR, Homma S (2003) Left ventricular mass and geometry and the risk of ischemic stroke. Stroke 34:2380–2384CrossRef
11.
Zurück zum Zitat Lee LJ, Kidwell CS, Alger J, Starkman S, Saver JL (2000) Impact on stroke subtype diagnosis of early diffusion-weighted magnetic resonance imaging and magnetic resonance angiography. Stroke 31:1081–1089CrossRef Lee LJ, Kidwell CS, Alger J, Starkman S, Saver JL (2000) Impact on stroke subtype diagnosis of early diffusion-weighted magnetic resonance imaging and magnetic resonance angiography. Stroke 31:1081–1089CrossRef
12.
Zurück zum Zitat Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D (1993) Survival after the onset of congestive heart failure in Framingham heart study subjects. Circulation 88:107–115CrossRef Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D (1993) Survival after the onset of congestive heart failure in Framingham heart study subjects. Circulation 88:107–115CrossRef
13.
Zurück zum Zitat Mohammed SF, Borlaug BA, Roger VL, Mirzoyev SA, Rodeheffer RJ, Chirinos JA, Redfield MM (2012) Comorbidity and ventricular and vascular structure and function in heart failure with preserved ejection fraction: a community-based study. Circ Heart Fail 5:710–719CrossRef Mohammed SF, Borlaug BA, Roger VL, Mirzoyev SA, Rodeheffer RJ, Chirinos JA, Redfield MM (2012) Comorbidity and ventricular and vascular structure and function in heart failure with preserved ejection fraction: a community-based study. Circ Heart Fail 5:710–719CrossRef
14.
Zurück zum Zitat Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P (2016) 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: The task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37:2129–2200CrossRef Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P (2016) 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: The task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37:2129–2200CrossRef
15.
Zurück zum Zitat Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440–1463CrossRef Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440–1463CrossRef
16.
Zurück zum Zitat Imazu M, Takahama H, Asanuma H, Funada A, Sugano Y, Ohara T, Hasegawa T, Asakura M, Kanzaki H, Anzai T, Kitakaze M (2014) Pathophysiological impact of serum fibroblast growth factor 23 in patients with nonischemic cardiac disease and early chronic kidney disease. Am J Physiol Heart Circ Physiol 307:H1504–H1511CrossRef Imazu M, Takahama H, Asanuma H, Funada A, Sugano Y, Ohara T, Hasegawa T, Asakura M, Kanzaki H, Anzai T, Kitakaze M (2014) Pathophysiological impact of serum fibroblast growth factor 23 in patients with nonischemic cardiac disease and early chronic kidney disease. Am J Physiol Heart Circ Physiol 307:H1504–H1511CrossRef
17.
Zurück zum Zitat Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57:450–458CrossRef Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57:450–458CrossRef
18.
Zurück zum Zitat Muiesan ML, Salvetti M, Monteduro C, Bonzi B, Paini A, Viola S, Poisa P, Rizzoni D, Castellano M, Agabiti-Rosei E (2004) Left ventricular concentric geometry during treatment adversely affects cardiovascular prognosis in hypertensive patients. Hypertension 43:731–738CrossRef Muiesan ML, Salvetti M, Monteduro C, Bonzi B, Paini A, Viola S, Poisa P, Rizzoni D, Castellano M, Agabiti-Rosei E (2004) Left ventricular concentric geometry during treatment adversely affects cardiovascular prognosis in hypertensive patients. Hypertension 43:731–738CrossRef
19.
Zurück zum Zitat Misirli HC, Yanar HT, Erdogan SN, Akkilic EC, Ozkan D, Bayram T, Araz O (2015) Frequency of left atrial dilatation in ischemic stroke. North Clin Istanb 2:7–12PubMedPubMedCentral Misirli HC, Yanar HT, Erdogan SN, Akkilic EC, Ozkan D, Bayram T, Araz O (2015) Frequency of left atrial dilatation in ischemic stroke. North Clin Istanb 2:7–12PubMedPubMedCentral
20.
Zurück zum Zitat Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A (2009) Revised equations for estimated gfr from serum creatinine in Japan. Am J Kidney Dis 53:982–992CrossRef Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A (2009) Revised equations for estimated gfr from serum creatinine in Japan. Am J Kidney Dis 53:982–992CrossRef
21.
Zurück zum Zitat Takashima N, Arima H, Kita Y, Fujii T, Miyamatsu N, Komori M, Sugimoto Y, Nagata S, Miura K, Nozaki K (2017) Incidence, management and short-term outcome of stroke in a general population of 1.4 million Japanese–Shiga Stroke Registry. Circ J 81:1636–1646CrossRef Takashima N, Arima H, Kita Y, Fujii T, Miyamatsu N, Komori M, Sugimoto Y, Nagata S, Miura K, Nozaki K (2017) Incidence, management and short-term outcome of stroke in a general population of 1.4 million Japanese–Shiga Stroke Registry. Circ J 81:1636–1646CrossRef
22.
Zurück zum Zitat Abdul-Rahim AH, Perez AC, Fulton RL, Jhund PS, Latini R, Tognoni G, Wikstrand J, Kjekshus J, Lip GY, Maggioni AP, Tavazzi L, Lees KR, McMurray JJ (2015) Risk of stroke in chronic heart failure patients without atrial fibrillation: Analysis of the controlled rosuvastatin in multinational trial heart failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'insufficienza Cardiaca-Heart Failure (GISSI-HF) trials. Circulation 131:1486–1494CrossRef Abdul-Rahim AH, Perez AC, Fulton RL, Jhund PS, Latini R, Tognoni G, Wikstrand J, Kjekshus J, Lip GY, Maggioni AP, Tavazzi L, Lees KR, McMurray JJ (2015) Risk of stroke in chronic heart failure patients without atrial fibrillation: Analysis of the controlled rosuvastatin in multinational trial heart failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'insufficienza Cardiaca-Heart Failure (GISSI-HF) trials. Circulation 131:1486–1494CrossRef
23.
Zurück zum Zitat Abdul-Rahim AH, Perez AC, MacIsaac RL, Jhund PS, Claggett BL, Carson PE, Komajda M, McKelvie RS, Zile MR, Swedberg K, Yusuf S, Pfeffer MA, Solomon SD, Lip GYH, Lees KR, McMurray JJV (2017) Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the charm-preserved and i-preserve trials. Eur Heart J 38:742–750PubMed Abdul-Rahim AH, Perez AC, MacIsaac RL, Jhund PS, Claggett BL, Carson PE, Komajda M, McKelvie RS, Zile MR, Swedberg K, Yusuf S, Pfeffer MA, Solomon SD, Lip GYH, Lees KR, McMurray JJV (2017) Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the charm-preserved and i-preserve trials. Eur Heart J 38:742–750PubMed
24.
Zurück zum Zitat Erkuner O, Dudink E, Nieuwlaat R, Rienstra M, Van Gelder IC, Camm AJ, Capucci A, Breithardt G, LeHeuzey JY, Lip GYH, Crijns H, Luermans J (2018) Effect of systemic hypertension with versus without left ventricular hypertrophy on the progression of atrial fibrillation (from the Euro Heart Survey). Am J Cardiol 122:578–583CrossRef Erkuner O, Dudink E, Nieuwlaat R, Rienstra M, Van Gelder IC, Camm AJ, Capucci A, Breithardt G, LeHeuzey JY, Lip GYH, Crijns H, Luermans J (2018) Effect of systemic hypertension with versus without left ventricular hypertrophy on the progression of atrial fibrillation (from the Euro Heart Survey). Am J Cardiol 122:578–583CrossRef
25.
Zurück zum Zitat Seko Y, Kato T, Haruna T, Izumi T, Miyamoto S, Nakane E, Inoko M (2018) Association between atrial fibrillation, atrial enlargement, and left ventricular geometric remodeling. Sci Rep 8:6366CrossRef Seko Y, Kato T, Haruna T, Izumi T, Miyamoto S, Nakane E, Inoko M (2018) Association between atrial fibrillation, atrial enlargement, and left ventricular geometric remodeling. Sci Rep 8:6366CrossRef
26.
Zurück zum Zitat Iwakura K, Okamura A, Koyama Y, Date M, Higuchi Y, Inoue K, Kimura R, Nagai H, Toyoshima Y, Ozawa M, Ito N, Shibuya M, Omiya S, Takagi T, Morisawa D, Fujii K (2011) Effect of elevated left ventricular diastolic filling pressure on the frequency of left atrial appendage thrombus in patients with nonvalvular atrial fibrillation. Am J Cardiol 107:417–422CrossRef Iwakura K, Okamura A, Koyama Y, Date M, Higuchi Y, Inoue K, Kimura R, Nagai H, Toyoshima Y, Ozawa M, Ito N, Shibuya M, Omiya S, Takagi T, Morisawa D, Fujii K (2011) Effect of elevated left ventricular diastolic filling pressure on the frequency of left atrial appendage thrombus in patients with nonvalvular atrial fibrillation. Am J Cardiol 107:417–422CrossRef
27.
Zurück zum Zitat Cioffi G, Mureddu GF, Stefenelli C, de Simone G (2004) Relationship between left ventricular geometry and left atrial size and function in patients with systemic hypertension. J Hypertens 22:1589–1596CrossRef Cioffi G, Mureddu GF, Stefenelli C, de Simone G (2004) Relationship between left ventricular geometry and left atrial size and function in patients with systemic hypertension. J Hypertens 22:1589–1596CrossRef
28.
Zurück zum Zitat Lam CS, Roger VL, Rodeheffer RJ, Bursi F, Borlaug BA, Ommen SR, Kass DA, Redfield MM (2007) Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted county, Minnesota. Circulation 115:1982–1990CrossRef Lam CS, Roger VL, Rodeheffer RJ, Bursi F, Borlaug BA, Ommen SR, Kass DA, Redfield MM (2007) Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted county, Minnesota. Circulation 115:1982–1990CrossRef
29.
Zurück zum Zitat Weitz JI, Fredenburgh JC, Eikelboom JW (2017) A test in context: D-dimer. J Am Coll Cardiol 70:2411–2420CrossRef Weitz JI, Fredenburgh JC, Eikelboom JW (2017) A test in context: D-dimer. J Am Coll Cardiol 70:2411–2420CrossRef
30.
Zurück zum Zitat Chung I, Choudhury A, Lip GY (2007) Platelet activation in acute, decompensated congestive heart failure. Thromb Res 120:709–713CrossRef Chung I, Choudhury A, Lip GY (2007) Platelet activation in acute, decompensated congestive heart failure. Thromb Res 120:709–713CrossRef
31.
Zurück zum Zitat Di Mascio R, Marchioli R, Vitullo F, Tognoni G (1996) A positive relation between high hemoglobin values and the risk of ischemic stroke. Progetto 3a investigators. Eur Neurol 36:85–88CrossRef Di Mascio R, Marchioli R, Vitullo F, Tognoni G (1996) A positive relation between high hemoglobin values and the risk of ischemic stroke. Progetto 3a investigators. Eur Neurol 36:85–88CrossRef
Metadaten
Titel
Ischemic stroke risk during post-discharge phases of heart failure: association of left ventricular concentric geometry
verfasst von
Yasuhiro Shintani
Hiroyuki Takahama
Yasuhiro Hamatani
Kunihiro Nishimura
Hideaki Kanzaki
Kengo Kusano
Teruo Noguchi
Kazunori Toyoda
Satoshi Yasuda
Chisato Izumi
Publikationsdatum
22.10.2019
Verlag
Springer Japan
Erschienen in
Heart and Vessels / Ausgabe 4/2020
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-019-01522-x

Weitere Artikel der Ausgabe 4/2020

Heart and Vessels 4/2020 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.